8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001564590-17-012131
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading abio-8k_20170601.htm…